#complex biologics

1 story

#ebitda #oncology #saroglitazar #specialty medicines #us launch #zydus lifesciences

Zydus Lifesciences Growth Strategy
Zydus forecasts steady growth for five years as innovation matures.
The Economic Times · 1m